EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients

Tianjiao Wang, Jean-Marc Navenot, Stavros Rafail, Cynthia Kurtis, Mark Carroll, Marian Van Kerckhoven, Sofie Van Rossom, Kelly Schats, Konstantinos Avraam, Robyn Broad, Karen Howe, Ashley Liddle und 21 weitere

Molecular Therapy - Methods & Clinical Development · 2024-06 · 32 (2) · 101265

DOI: 10.1016/j.omtm.2024.101265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy - Methods & Clinical Development, 2024-06. Verfasst von Tianjiao Wang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biomarkers & Companion Diagnostics, Adaptimmune, Philadelphia, PA, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HLAMAGE-A4T cell receptorT cell therapyassay validationbiomarkerclinical trialimmunotherapypatient screeningprecision medicine

Autor:innen und Institutionen

  • Clinical Biomarkers & Companion Diagnostics, Adaptimmune, Philadelphia, PA, USA.
  • Biomarker Discovery and Platform, Adaptimmune, Philadelphia, PA, USA.
  • Information Management Clinical Systems, Adaptimmune, Philadelphia, PA, USA.
  • Assay Development Histopathology, CellCarta, Antwerpen, Belgium.
  • Histopathology & Image Quantification Unit, CellCarta, Antwerpen, Belgium.
  • Translational Sciences, Adaptimmune, Abingdon, Oxfordshire, UK.

Zitieren

APA

Wang, T., Navenot, J. M., Rafail, S., Kurtis, C., Carroll, M., Van Kerckhoven, M., Van Rossom, S., Schats, K., Avraam, K., Broad, R., Howe, K., Liddle, A., Clayton, A., Wang, R., Quinn, L., Sanderson, J. P., McAlpine, C., Carozza, C., Pimpinella, E., …, & Blumenschein, G. R. (2024). Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients. Molecular Therapy - Methods & Clinical Development, 32(2), 101265. https://doi.org/10.1016/j.omtm.2024.101265

Vancouver

Wang T, Navenot JM, Rafail S, Kurtis C, Carroll M, Van Kerckhoven M, et al. Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients. Molecular Therapy - Methods & Clinical Development. 2024;32(2):101265. doi:10.1016/j.omtm.2024.101265

BibTeX
@article{Wang2024,
  author = {Wang, Tianjiao and Navenot, Jean-Marc and Rafail, Stavros and Kurtis, Cynthia and Carroll, Mark and Van Kerckhoven, Marian and Van Rossom, Sofie and Schats, Kelly and Avraam, Konstantinos and Broad, Robyn and Howe, Karen and Liddle, Ashley and Clayton, Amber and Wang, Ruoxi and Quinn, Laura and Sanderson, Joseph P and McAlpine, Cheryl and Carozza, Carly and Pimpinella, Eric and Hsu, Susan and Brophy, Francine and Elefant, Erica and Bayer, Paige and Williams, Dennis and Butler, Marcus O and Clarke, Jeffrey M and Gainor, Justin F and Govindan, Ramaswamy and Moreno, Victor and Johnson, Melissa and Tu, Janet and Hong, David S and Blumenschein, George R},
  title = {Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients},
  journal = {Molecular Therapy - Methods & Clinical Development},
  year = {2024},
  volume = {32},
  number = {2},
  pages = {101265},
  doi = {10.1016/j.omtm.2024.101265}
}
Kostenlos starten →